A new class of pH-responsive multivalent host–guest interactions to manipulate polypeptide-based nano-vehicles was developed. Poly(l-lysine) (poly(Lys)) grafted with β-cyclodextrin and 2,3-dimethylmaleic acid was coupled with oleic acid. This new polymer was utilized to fabricate pH-responsive nano-vehicles for antitumor drug doxorubicin delivery. The host–guest (zipping) interaction between β-cyclodextrin and 2,3-dimethylmaleic acid moieties and the hydrophobic interaction between the oleic acid molecules contributed to form self-assembled nano-vehicles. 2,3-Dimethylmaleic acid moieties were highly degradable at a slightly acidic pH (~pH 6.8). These nano-vehicles increased the release of the encapsulated doxorubicin content (by the unzipping interaction between β-cyclodextrin and degraded 2,3-dimethylmaleic acid moieties) when the pH of the solution decreased to 6.8. This event caused a significant increase in the efficiency of cellular doxorubicin uptake and in vitro tumor inhibition.
FerrariMBarkerADowningG. A cancer nanotechnology strategy. NanoBiotechnology2005; 1: 129–131.
2.
ZhangXXuHNewazZ. Synthesis and characterization of a pH- and enzyme-sensitive poly(ethylene glycol)–hyaluronic acid–melphalan prodrug. J Bioact Compat Pol2013; 28: 527–539.
3.
NguyenDHBaeJWChoiJH. Bioreducible cross-linked pluronic micelles: pH-triggered release of doxorubicin and folate-mediated cellular uptake. J Bioact Compat Pol2013; 28: 341–354.
4.
SonJSYooHS. pH-responsive microspheres encapsulated with iron oxide nanoaggregates for gastrointestinal delivery. J Bioact Compat Pol2012; 27: 54–66.
5.
GanYCYuanJFLiuXJ. ABC triblock copolymers with pH-responsive LCST for controlled drug delivery. J Bioact Compat Pol2011; 26: 173–190.
6.
ChenDJiangXHuangY. pH-sensitive mPEG-Hz-cholesterol conjugates as a liposome delivery system. J Bioact Compat Pol2010; 25: 527–542.
7.
SadeghiMHosseinzadehH. Synthesis of starch-poly(sodium acrylate-co-acrylamide) superabsorbent hydrogel with salt and pH-responsiveness properties as a drug delivery system. J Bioact Compat Pol2008; 23: 381–404.
8.
ZhaoLMitomoHYoshF. Synthesis of pH-sensitive and biodegradable CM-cellulose/chitosan polyampholytic hydrogels with electron beam irradiation. J Bioact Compat Pol2008; 23: 319–333.
ParkSYBaikHJOhYT. A smart polysaccharide/drug conjugate for photodynamic therapy. Angew Chem Int Edit2011; 50: 1644–1647.
11.
LeeESNaKBaeYH. Super pH-sensitive multifunctional polymeric micelle. Nano Lett2005; 5: 325–329.
12.
LeeESKimDYounYS. A virus-mimetic nanogel vehicle. Angew Chem Int Edit2008; 47: 2418–2421.
13.
OhNMKwagDSParkSY. Electrostatic charge conversion processes in engineered tumor-identifying polypeptides for targeted chemotherapy. Biomaterials2012; 33: 1884–1893.
14.
LeeBROhKTOhYT. A novel pH-responsive polysaccharidic ionic complex for proapoptotic (KLAKLAK)2 peptide delivery. Chem Commun2011; 47: 3852–3854.
15.
OhKTYinHLeeES. Polymeric nano-vehicles for anticancer drugs with triggering release mechanisms. J Mater Chem2007; 17: 3987–4001.
16.
SchmaljohannD. Thermo- and pH-responsive polymers in drug delivery. Adv Drug Deliver Rev2006; 58: 1655–1670.
17.
PingYHuQTangG. FGFR-targeted gene delivery mediated by supramolecular assembly between β-cyclodextrin-crosslinked PEI and redox-sensitive PEG. Biomaterials2013; 34: 6482–6494.
18.
Van Dijk-WolthuisWNEvan de WaterLvan de WeteringP. Synthesis and characterization of poly-L-lysine with controlled low molecular weight. Macromol Chem Physic1997; 198: 3893–3906.
19.
OhNMOhKTBaikHJ. A self-organized 3-diethylaminopropyl-bearing glycol chitosan nanogel for tumor acidic pH targeting: evaluation. Colloid Surface B2010; 78: 120–126.
20.
TannockIFRotinD. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res1989; 49: 4373–4384.
21.
StubbsMMcSheehyPMGriffithsJR. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today2000; 6: 15–19.
22.
GilliesRJRaghunandNGarcia-MartinML. A review of pH measurement methods and applications in cancers. IEEE Eng Med Biol Mag2004; 23: 57–64.
23.
FerrariM. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer2005; 5: 161–171.
24.
GilliesERFrechetJM. pH-responsive copolymer assemblies for controlled release of doxorubicin. Bioconjug Chem2005; 16: 361–368.
25.
MaedaHMatsumuraY. EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy. Adv Drug Deliver Rev2011; 63: 129–130.
26.
ParkJHKwonSLeeM. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. Biomaterials2006; 27: 119–126.
27.
KavazDOdabaşSGüvenE. Bleomycin loaded magnetic chitosan nanoparticles as multifunctional nanocarriers. J Bioact Comp Pol2010; 25: 305–318.
28.
PereiraVHSalgadoAJOliveiraJM. In vivo biodistribution of carboxymethyl-chitosan/poly(amidoamine) dendrimer nanoparticles in rats. J Bioact Compat Pol2011; 26: 619–627.
